Skip to main content
. 2019 Nov 21;14(11):e0225575. doi: 10.1371/journal.pone.0225575

Table 5. Factors associated with the occurrence of drug resistance-associated mutations in ART-naive patients.

Factors            Category Prevalence of mutation, n (%)
Demographic Presence Absence OR (CI), p-value
Gender Male 9 (13.8) 56 (86.2) 1.70 (0.64–4.53), 0.287
  Female 9 (8.7) 95 (91.3) 1
Age (years) 19–29 5 (9.1) 50 (90.9) 0.51 (0.15–1.75), 0.287
  30–40 6 (8.5) 65 (91.5) 0.48 (0.15–1.52), 0.210
  > 40 7 (16.3) 36 (83.7) 1
Region Northwest 8 (15.1) 45 (84.9) 1.88 (0.70–5.09), 0.206
  Southwest 10 (8.6) 106 (91.4) 1
A treatment centre in the municipality Out 13 (14.3) 78 (85.7) 2.43 (0.83–7.16), 0.098
  Within 5 (6.4) 73 (93.6 1
Socio-economic      
Level of education Low (≤ 7) 12 (14.3) 72 (85.7) 2.19 (0.78–6.15), 0.128
 (years of school) High (> 7) 6 (7.1) 79 (92.9)  
Income level (XAF) ≤ 50,000 12 (9.2) 119 (90.8) 0.54 (0.19–1.54), 0.243
 (50000 ~100 USD) > 50,000 6 (15.8) 32 (84.2) 1
Behavioural      
Alcohol use Yes 9 (11.5) 69 (88.5) 1.19 (0.45–3.16), 0.729
  No 9 (9.9) 82 (90.1) 1
Smoking Yes 2 (16.7) 10 (83.3) 1.76 (0.35–8.76), 0.483
  No 16 (10.2) 141 (89.8) 1
Clinical history      
CD4+ status (cells/ml) < 200 2 (5.9) 32 (94.1) 0.97 (0.13–7.31), 0.975
  200–499 5 (10.4) 43 (89.6) 1.80 (0.33–9.90), 0.498
  ≥ 500 2 (6.1) 31 (93.9) 1
HIV subtypes Single forms 4 (10.3) 35 (89.7) 0.95 (0.29–3.06), 0.927
  Recombinant 14 (10.8) 116 (89.2) 1
 HIV Log10 viral load ≥ 5.2 copies/ml 15 (17.6) 70 (82.4) 5.79 (1.61–20.8), 0.007
  < 5.2 copies/ml 3 (3.6) 81 (96.4) 1